NARA Discovery
Article Details
← Back to Search Results
Journal Article

The Advanced Integrated Respiratory (AIR) Model: Integration of Air–Liquid Interface Cell Cultures within a Human Airway Model for Inhalation Toxicology

Patrick He; Hanieh Gholizadeh; Damien Chong; Shaokoon Cheng; Patrick Spicer; Paul Michael Young; Lois Ledo; Vanessa Wilson; Daniela Traini; Hui Xin Ong
Pharmaceutical Research · Vol. 43, Issue 3 · pp. 823-832 · 2026

Abstract

Purpose The Advanced Integrated Respiratory (AIR) model was developed as a physiologically relevant benchtop system designed to assess aerosol deposition and interactions within the respiratory tract. Methods This model integrates a three-dimensional (3D) cast of the human airways with a vacuum driven aerosol inhalation flow and an air liquid interface (ALI) cell culture platform. In this study, the integrated AIR and ALI cell model was used to investigate the toxicity profile of aerosolized Ricinus communis agglutinin-1 (RCA I) toxin. RCA I was characterized in terms of particle size, surface charge, rheology, and aerosol performance. Additionally, real-time electrochemical detection using the Micro Analytical Device (MAD) provided high sensitivity quantification of aerosolized RCA I. The biological effects were assessed using human epithelial cells cultured under ALI conditions, which were exposed to RCA I aerosols. Cytotoxicity and barrier function assays were performed to evaluate its impact. Results Results show significant differences in toxic dose thresholds comparing 2D and AIR models. Transport study revealed that RCA I exhibited significantly increased mass transport across the epithelial cell layer at toxic concentrations compared to non-toxic concentrations. Conclusions This integrated approach represents a significant advancement in the study of inhaled aerosol deposition, toxicity, and pharmacokinetics, offering a robust tool for predicting lung injury and enhancing the detection of a wide range of inhaled aerosols, including but not limited to toxins.

Bibliographic Information

JournalPharmaceutical Research
PublisherSpringer
Publication Date2026-03-01
Publication Year2026
Volume43
Issue3
Pages823-832
Document TypeJournal Article
Print ISSN0724-8741
eISSN1573-904X
DOI10.1007/s11095-026-04037-z

Access Information

NARA Access Coverage1984-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11095
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.